Researchers at CU Boulder have developed a platform which can quickly identify common mutations on the SARS-CoV-2 virus that allow it to escape antibodies and infect cells.
CU Boulder is ramping up its ability to conduct COVID-19 monitoring analyses by enlisting volunteer graduate students and postdocs across campus, including several from the Department of Chemical and Biological Engineering.
A multidisciplinary team is working to build a pilot-scale system capable of producing 10,000 to 100,000 doses of COVID-19 vaccines per run that would be ready for use as human trials of vaccines begin in the next year.
